Put Options

9 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$186.94 - $252.92 $336,492 - $455,256
-1,800 Reduced 1.52%
116,700 $28.5 Million
Q2 2024

Aug 14, 2024

SELL
$173.83 - $220.63 $25.6 Million - $32.5 Million
-147,400 Reduced 55.43%
118,500 $22.7 Million
Q1 2024

May 15, 2024

BUY
$165.79 - $198.03 $18.3 Million - $21.9 Million
110,600 Added 71.22%
265,900 $52.7 Million
Q4 2023

Feb 14, 2024

BUY
$134.65 - $174.81 $5.31 Million - $6.89 Million
39,400 Added 33.99%
155,300 $26.7 Million
Q3 2023

Nov 14, 2023

BUY
$136.29 - $225.35 $14.2 Million - $23.5 Million
104,100 Added 882.2%
115,900 $17.1 Million
Q2 2023

Aug 14, 2023

SELL
$209.98 - $240.96 $3.32 Million - $3.81 Million
-15,800 Reduced 57.25%
11,800 $2.58 Million
Q1 2023

May 15, 2023

SELL
$205.07 - $236.53 $8.8 Million - $10.1 Million
-42,900 Reduced 60.85%
27,600 $6.04 Million
Q4 2022

Feb 14, 2023

BUY
$205.77 - $233.97 $925,965 - $1.05 Million
4,500 Added 6.82%
70,500 $14.7 Million
Q3 2022

Nov 14, 2022

BUY
$212.32 - $243.58 $8.92 Million - $10.2 Million
42,000 Added 175.0%
66,000 $14.4 Million

Others Institutions Holding RMD

About RESMED INC


  • Ticker RMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 146,459,008
  • Market Cap $35.4B
More about RMD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.